George Grofik | executive |
Pablo Legorreta | executive |
Marshall Urist | executive |
Christopher Hite | executive |
Terrance Coyne | executive |
Chris Shibutani | analyst |
Geoffrey Meacham | analyst |
Peter Verdult | analyst |
Michael DiFiore | analyst |
Steve Scala | analyst |
Umer Raffat | analyst |
Ladies and gentlemen, thank you for standing by. Welcome to Royalty Pharma First Quarter 2024 Earnings Conference Call.
I would like now to turn the conference over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead, sir.
Good morning and good afternoon to everyone on the call.